Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5VGM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,498
Award facts
- Contract value 100% obligated
- $15,497.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $15,497.75 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds the underlying indefinite delivery contract with the Defense Logistics Agency and demonstrates consistent capability in fulfilling government contracts for essential pharmaceutical and medical commodities across multiple therapeutic domains. The delivery order reflects the company's versatility in handling both high-volume and specialized pharmaceutical supply requirements for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F5VGM?
SPE2DR26F5VGM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F5VGM worth?
The government has obligated $15,498 on SPE2DR26F5VGM.
Is contract SPE2DR26F5VGM an order under another contract?
Yes. SPE2DR26F5VGM is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VGM competed?
The extent of competition for SPE2DR26F5VGM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award